Literature DB >> 2654965

Pharmacogenetic perspectives gained from twin and family studies.

E S Vesell1.   

Abstract

Mesh：

Year:  1989        PMID： 2654965     DOI： 10.1016/0163-7258(89)90130-7

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  17 in total

Review 1.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

Review 2.  Current progress in pharmacogenetics.

Authors:  John D Blakey; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

3.  Bone mass pharmacogenetics and ethnic health implications.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

4.  The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers.

Authors:  Suayib Yalçin
Journal:  Gastrointest Cancer Res       Date:  2009-09

Review 5.  Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.

Authors:  Marwa Matboli; Sarah El-Nakeep; Nourhan Hossam; Alaa Habieb; Ahmed E M Azazy; Ali E Ebrahim; Ziad Nagy; Omar Abdel-Rahman
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 6.  Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.

Authors:  Victor E Ortega; Deborah A Meyers
Journal:  J Allergy Clin Immunol       Date:  2014-01       Impact factor: 10.793

7.  Using patient DNA to optimize therapy in heart failure patients: a move toward perfection.

Authors:  Howard L McLeod
Journal:  Heart Fail Rev       Date:  2010-05       Impact factor: 4.214

Review 8.  Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.

Authors:  Lucy Gossage; Srinivasan Madhusudan
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?

Authors:  Janine E Micheli; Leslie W Chinn; Sarah B Shugarts; Ashish Patel; Jeffrey N Martin; David R Bangsberg; Deanna L Kroetz
Journal:  Pharmacogenet Genomics       Date:  2013-11       Impact factor: 2.089

Review 10.  Pharmacogenetics and the development of personalized approaches for combination therapy in asthma.

Authors:  Stacey M Miller; Victor E Ortega
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.